micro-community-banner
 
  • Saved

3yr
Real-world evaluation of weekly subcutaneous treatment with semaglutide in a cohort of Italian diabetic patients - Journal of Endocrinological Investigation

Real-world evaluation of weekly subcutaneous treatment with semaglutide in a cohort of Italian diabetic patients - Journal of Endocrinological Investigation

Source : https://link.springer.com/article/10.1007/s40618-022-01799-2

Purpose Registered trials and real-world evidence (RWE) studies provided evidence on the efficacy of once-weekly (OW) semaglutide on hyperglycaemia and cardiovascular risk factors as add-on or de-novo treatment in type...



Conclusions: Real-world evaluation of weekly subcutaneous treatment with semaglutide in a cohort of Italian diabetic patients.

  • Saved

3yr
Type 2 Diabetes

Over 34 million1 Americans have diabetes, and 90-95%2 of them have Type 2 Diabetes. When diet and lifestyle changes fail to improve glycemic control, metformin3 is typically the first treatment prescribed. Several novel drugs and classes have emerged to treat Type 2 Diabetes after or in addition to metformin. These include GLP-1 receptor agonists, DPP-4 and SGLT2 inhibitors.




  • What factors do you consider when adding to or switching from metformin?

  • What have been your experiences with some of the newer/novel Type 2 Diabetes drugs and classes?



 



References:




  1. National Diabetes Statistics Report, 2020

  2. CDC Diabetes Basics, accessed 11 Jan 2022

  3. Mayo Clinic Type 2 Diabetes Diagnosis and Treatment, accessed 11 Jan 2022


  • 3yr
    Incretin therapy is key as there is a relative deficiency or decreased responsiveness in metabolic syndrome and type 2 DM. With the GIP moiety being added to the GLP-1 Show More
  • 3yr
    Rybelsus ( it is oral Ozempic Semaglutide ) has come up as a block buster diabetic medicine in both managing diabetes and Obeisty , having phenomenal results that Show More

Show More Comments

  • Saved

3yr
Type 2 Diabetes

Over 34 million1 Americans have diabetes, and 90-95%2 of them have Type 2 Diabetes. When diet and lifestyle changes fail to improve glycemic control, metformin3 is typically the first treatment prescribed. Several novel drugs and classes have emerged to treat Type 2 Diabetes after or in addition to metformin. These include GLP-1 receptor agonists, DPP-4 and SGLT2 inhibitors.

  • What factors do you consider when adding to or switching from metformin?
  • What have been your experiences with some of the newer/novel Type 2 Diabetes drugs and classes?

 

References:

  1. National Diabetes Statistics Report, 2020
  2. CDC Diabetes Basics, accessed 11 Jan 2022
  3. Mayo Clinic Type 2 Diabetes Diagnosis and Treatment, accessed 11 Jan 2022
  • 3yr
    Incretin therapy is key as there is a relative deficiency or decreased responsiveness in metabolic syndrome and type 2 DM. With the GIP moiety being added to the GLP-1 Show More
  • 3yr
    Rybelsus ( it is oral Ozempic Semaglutide ) has come up as a block buster diabetic medicine in both managing diabetes and Obeisty , having phenomenal results that Show More

Show More Comments

  • Saved

3yr
Type 2 Diabetes

Over 34 million1 Americans have diabetes, and 90-95%2 of them have Type 2 Diabetes. When diet and lifestyle changes fail to improve glycemic control, metformin3 is typically the first treatment prescribed. Several novel drugs and classes have emerged to treat Type 2 Diabetes after or in addition to metformin. These include GLP-1 receptor agonists, DPP-4 and SGLT2 inhibitors.




  • What factors do you consider when adding to or switching from metformin?

  • What have been your experiences with some of the newer/novel Type 2 Diabetes drugs and classes?



 



References:




  1. National Diabetes Statistics Report, 2020

  2. CDC Diabetes Basics, accessed 11 Jan 2022

  3. Mayo Clinic Type 2 Diabetes Diagnosis and Treatment, accessed 11 Jan 2022


  • 3yr
    Incretin therapy is key as there is a relative deficiency or decreased responsiveness in metabolic syndrome and type 2 DM. With the GIP moiety being added to the GLP-1 Show More
  • 3yr
    Rybelsus ( it is oral Ozempic Semaglutide ) has come up as a block buster diabetic medicine in both managing diabetes and Obeisty , having phenomenal results that Show More

Show More Comments

  • Saved

3yr
Type 2 Diabetes

Over 34 million1 Americans have diabetes, and 90-95%2 of them have Type 2 Diabetes. When diet and lifestyle changes fail to improve glycemic control, metformin3 is typically the first treatment prescribed. Several novel drugs and classes have emerged to treat Type 2 Diabetes after or in addition to metformin. These include GLP-1 receptor agonists, DPP-4 and SGLT2 inhibitors.




  • What factors do you consider when adding to or switching from metformin?

  • What have been your experiences with some of the newer/novel Type 2 Diabetes drugs and classes?



 



References:




  1. National Diabetes Statistics Report, 2020

  2. CDC Diabetes Basics, accessed 11 Jan 2022

  3. Mayo Clinic Type 2 Diabetes Diagnosis and Treatment, accessed 11 Jan 2022


  • 3yr
    Incretin therapy is key as there is a relative deficiency or decreased responsiveness in metabolic syndrome and type 2 DM. With the GIP moiety being added to the GLP-1 Show More
  • 3yr
    Rybelsus ( it is oral Ozempic Semaglutide ) has come up as a block buster diabetic medicine in both managing diabetes and Obeisty , having phenomenal results that Show More

Show More Comments